RE-BVS – Piemonte Repository

Sfoglia per AUTORE
BARBARINI G
Collezione ASL Città di Torino

Items : 8

Factors Enhancing Treatment of Hepatitis C Virus-Infected Italian People Who Use Drugs: The CLEO-GRECAS Experience. in The American journal of gastroenterology / Am J Gastroenterol. 2021 Jun 1;116(6):1248-1255. doi: 10.14309/ajg.0000000000001147.

2021
ASL Città di Torino

Rinaldi L; Messina V; Di Marco V; Iovinella V; Claar E; Cariti G; Sacco R; De Luca M; Scifo G; Gatti P; Barbarini G; Pace Palitti V; Quartini M; Tundo P; D'Offizi G; Parruti G; di Rosolini MA; Garrucciu G; Cosco L; Benanti F; Gimignani G; Vespasiani Gentilucci U; Di Lorenzo F; D'Antò M; Nevola R; Lupia T; Rosato V; Morbiducci V; Luzzitelli I; et alii...

Sustained virological response in patients with HCV treated with daclatasvir plus sofosbuvir, with or without ribavirin: a large, field-practice study. in Drugs in context / Drugs Context. 2020 Dec 15;9:2020-4-11. doi: 10.7573/dic.2020-4-11. eCollection 2020.

2020
ASL Città di Torino

Sacco R; Messina V; Gentilucci UV; Adinolfi LE; Ascione A; Barbarini G; Barlattani A; Cariti G; Cozzolongo R; Fimiani B; Francavilla R; Furlan C; Garrucciu G; Iovinella V; Rinaldi L; Marignani M; Begini P; Palitti VP; Pellicelli AM; Scifo G; Facciorusso A; Giacomelli L; Shah A; Bertino G; Perazzo S; Bresci G; Izzi A;

Treatment with direct-acting antivirals in a multicenter cohort of HCV-infected inmates in Italy. in The International journal on drug policy / Int J Drug Policy. 2018 Sep;59:50-53. doi: 10.1016/j.drugpo.2018.06.017. Epub 2018 Jul 6.

2018
ASL Città di Torino

Pontali E; Fiore V; Ialungo AM; Ranieri R; Mollaretti O; Barbarini G; Marri D; Prestileo T; Dell'Isola S; Rastrelli E; Leo G; Starnini G; Babudieri S; Madeddu G;

Dolutegravir Plus Rilpivirine as a Switch Option in cART-Experienced Patients: 96-Week Data. in The Annals of pharmacotherapy / Ann Pharmacother. 2018 Aug;52(8):740-746. doi: 10.1177/1060028018761600. Epub 2018 Feb 26.

2018
ASL Città di Torino

Capetti AF; Cossu MV; Sterrantino G; Barbarini G; Di Giambenedetto S; De Socio GV; Orofino G; Di Biagio A; Celesia BM; Rusconi S; Argenteri B; Rizzardini G;

A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks' observational data. in BMC infectious diseases / BMC Infect Dis. 2017 Sep 30;17(1):658. doi: 10.1186/s12879-017-2755-4.

2017
ASL Città di Torino

Capetti AF; Cossu MV; Orofino G; Sterrantino G; Cenderello G; De Socio GV; Cattelan AM; Soria A; Rusconi S; Riccardi N; Baldin GM; Niero FP; Barbarini G; Rizzardini G;

Management of HCV infection in the penitentiary setting in the direct-acting antivirals era: practical recommendations from an expert panel. in Infection / Infection. 2017 Apr;45(2):131-138. doi: 10.1007/s15010-016-0973-0. Epub 2016 Dec 26.

2017
ASL Città di Torino

Ranieri R; Starnini G; Carbonara S; Pontali E; Leo G; Romano A; Panese S; Monarca R; Prestileo T; Barbarini G; Babudieri S;

Erratum to: Management of HCV infection in the penitentiary setting in the direct-acting antivirals era: practical recommendations from an expert panel. in Infection / Infection. 2017 Apr;45(2):249. doi: 10.1007/s15010-017-0983-6.

2017
ASL Città di Torino

Ranieri R; Starnini G; Carbonara S; Pontali E; Leo G; Romano A; Panese S; Monarca R; Prestileo T; Barbarini G; Babudieri S;

Switch to Dolutegravir plus Rilpivirine Dual Therapy in cART-Experienced Subjects: An Observational Cohort. in PloS one / PLoS One. 2016 Oct 14;11(10):e0164753. doi: 10.1371/journal.pone.0164753. eCollection 2016.

2016
ASL Città di Torino

Capetti AF; Sterrantino G; Cossu MV; Orofino G; Barbarini G; De Socio GV; Di Giambenedetto S; Di Biagio A; Celesia BM; Argenteri B; Rizzardini G;